Abstract: Embodiments provide apparatus and methods for delivering solid form medications such as pellets to various locations in the body. One embodiment provides an apparatus for in vivo delivery of medication pellets comprising a first chamber including an opening; a second chamber substantially surrounding the first chamber, a carriage disposed in the first chamber, a mechanism for transferring the medication pellets from the first chamber to the second chamber and a pusher plate. The carriage can hold and dispense a plurality of medication pellets. Each pellet contains a selected dose of drug to treat a medical condition. A catheter is positioned in the second chamber. The catheter has a lumen sized for the pellet, a proximal end inside the chamber and a distal end extending through chamber opening to deliver the pellet to a delivery site. The pusher plate engages and advances the pellet though the catheter to the delivery site.

Abstract: This invention discloses a novel microneedle system, phase-transition microneedles (PTM), of which the microneedles formed of hydrophilic polymers are swelling but insoluble when absorbing water due to their internal cross-linked network through microcrystalline domains functioning as cross-linking junctions. The microneedles are sufficiently hard to penetrate the epidermis of the skin at dry state, but are converted to hydrogel state to release their loaded cargos by absorbing the body fluid in the dermis layer, and able to be withdrawn from the skin completely (without depositing needle tip materials in the skin) because of their insoluble network. Moreover, formation of the insoluble polymeric network through microcrystalline domains of PTM is achieved by a mild freeze-thaw treatment, for which bio-active agents may be loaded safely in the microneedle tips by adding in the polymer solution prior to molding without denaturing.

Abstract: Connector including a primary female connector having a form of a tapered cone having an opening at its deepest point, and a spring loaded insert configured to be inserted through said opening essentially along a central axis of said primary female connector.

Abstract: A device for administering a fluid includes a housing that holds a sterilization cassette having a shell, a fluid chamber, and a light transmitting window. An input directs fluid into the chamber. A light source is positioned to direct ultraviolet or other light through the window into the fluid chamber at an intensity sufficient to kill or render non-reproducible at least one species of a microorganism in the fluid while the fluid is in the chamber. An outlet receives fluid from the cassette and directs the fluid to a destination. The fluid is substantially uniformly exposed to the light while in the chamber. The cassette and light source are contained in a housing that prevents light from escaping the housing.

Abstract: A multi-use intravenous infusion assembly is presented which includes a septum actuator having various features to prevent over-insertion of the septum actuator through a slit in a blood control septum. By preventing over-insertion of the septum actuator, the slit of the septum is able to repeatedly self-close following removal of an external Luer device. Thus, the intravenous infusion assembly may be used repeatedly without exposing a clinician to blood and other infusion fluids.

Abstract: A urine control device to be placed intermediate a catheter and a collection bag is provided. The urine control device includes first and second bell shaped housings with a magnetic valve disposed between the first and the second housings. When the pressure from the urine which flows through the present catheter enters the first chamber and exceeds the magnetic attraction in the valve, the valve pivotally opens, permitting the urine to flow through the open valve and into the second chamber. Due to the shape of the chambers, secondary forces create a low pressure zone in the second chamber which helps empty the bladder fully. Once the flow ceases, the magnetic valve pivotally shuts, allowing the urine pressure to build once again. Various sample ports and air entry ports may be provided on the device.

Abstract: An implantable medical device comprises a non-volatile memory circuit including a configuration memory portion to store auto-configuration data for the IMD, a controller circuit, a reset circuit adapted to generate a reset signal and disable the controller circuit, and a startup circuit adapted to transfer the auto-configuration data from the configuration memory portion to one or more configuration registers in response to the reset signal, wherein values of the one or more configuration registers configure the IMD for a safety mode operation.

Abstract: A method and system improves the effectiveness of cardioversion or defibrillation through the ability to switch shock vectors and to reduce transthoracic impedance. An external multiple patch system comprises at least two options for a shocking vector once external patches are applied and adhered to desired locations on a patient's body. A manual switching mechanism in the system provides the ability to direct current from a defibrillator to either of two or more adhesive electrode patches. A method and system of decreasing transthoracic impedance comprises wrapping material around a patient's body to apply pressure to adhered patches, which further reduces transthoracic impedance by increasing effective pressure on the patches through use of pressure-focusing mechanisms located between a patch and a strap.

Abstract: A dual purpose sleep wearable headgear for both monitoring and stimulating the brain of a sleeping person is disclosed that provides a simple to use and safe platform for wearing consumer-type dual use brain stimulation and monitoring devices during sleep. The headgear enables a user to sleep comfortably while wearing the electronics and related electrodes needed for both EEG monitoring and transcranial electrical stimulation. The headgear can accept and support a miniaturized dual use monitoring/stimulation device on the forehead or the top of the head, where the bulk of the monitoring/stimulation device will not interfere with the user's sleeping position. The headgear disclosed takes the guesswork out of electrode placement, because the electrodes are prepositioned or are easily adjustable according to a predetermined pattern of electrode placement, and are appropriately sized so as to allow comfortable transcranial stimulation without producing skin irritation, and without awakening the user.

Abstract: An implantable lead connector configured for long term implantation and to electrically interconnect multiple medical devices and to channel electrical signals between said interconnected devices and a target organ, comprising: a first port adapted to receive a first signal suitable to stimulate a target tissue, a second port adapted to receive a second signal suitable to stimulate a target tissue, and a third port configured to connect to a target organ, wherein at least one of said first and second ports is configured to connect to a signal generator not integrated with said connector.

Abstract: A cochlear implant arrangement is described for creating sound perception in an implanted patient. An implant electrode contains electrode wires for carrying stimulation signals to corresponding electrode contacts distributed along a length of an outer surface of an apical electrode array section of the implant electrode. An apical portion of the electrode array is characterized by a tendency to fold back against a more basal section of the electrode array when inserted into a cochlea of the patient. An implantable stimulation processor produces the stimulation signals such that each electrode contact, including any in a folded back portion, delivers stimulation signals for a frequency band defined based on a function of spatial spread of stimulation voltage and correctly associated with tonotopic frequency response of the adjacent neural tissue.

Abstract: A stylet-lead assembly includes a therapy delivery element and a stylet. The therapy delivery element includes a proximal end, a distal end, and a lumen having a lumen length extending from the proximal end to almost the distal end. The stylet includes a stylet handle including a locking insert having a first channel adapted to receive a proximal end of a stylet wire. A portion of the stylet wire extending beyond a proximal end of the locking insert includes at least one bend. The stylet handle has an opening at a distal end adapted to compressively engage the proximal end of the stylet wire to the locking insert, such that an exposed portion of the stylet wire measured from a distal end of the stylet wire to a distal end of the locking insert generally comprises the lumen length.

Abstract: A neurostimulation lead includes a lead body having a proximal portion and a distal portion and a first conductor extending through the lead body. An electrode cuff can be secured relative to the distal portion of the lead body. The electrode cuff includes a cuff body, a first tendril extending from a first region of the cuff body, a second tendril extending from a second region of the cuff body and a first electrode disposed on the cuff body and electrically connected to the first conductor.

Abstract: The present invention relates to materials having therapeutic compositions releasably contained within the materials. The materials are configured to release therapeutic compositions at a desired rate. The present invention also relates to devices incorporating the materials.

Abstract: A lead anchor includes a body with opposing first and second major surfaces and at least one edge surface between the first and second major surfaces. The body defines a first channel, a second channel, and a notch. The first channel extends from the edge surface of the body and is open at the first major surface. The second channel extends from the edge surface of the body and is open at the second major surface. The notch extends from the edge surface of the body, defines an opening from the first major surface through the body to the second major surface, and intersects the first channel and the second channel. The first channel, the second channel, and a portion of the notch define a passage through the body so that a lead can be inserted into the notch and turned to dispose a portion of the lead within the passage. The lead anchor can be part of a kit or system that also includes a lead.

Abstract: A vaginal rehabilitative device comprising: a vaginal electrical stimulation applicator; and a control module connectable by a wire to said applicator and comprising a user interface for controlling electrical stimuli by said applicator and a display module configured to display data received from said applicator.

Abstract: Methods for treating a renal associated condition in a subject are provided. Aspects of the subject methods include paradoxically enhancing renal sympathetic bias in the subject in a manner effective to treat the renal associated condition. Also provided are compositions, kits and systems for practicing the subject methods.

Abstract: An apparatus for generating focused currents in biological tissue is provided. The apparatus comprises an electric source capable of generating an electric field across a region of tissue and means for altering the permittivity of the tissue relative to the electric field, whereby a displacement current is generated. The means for altering the permittivity may be a chemical source, optical source, mechanical source, thermal source, or electromagnetic source.

Abstract: Approaches are described for fitting an implanted cochlear implant electrode array having stimulation electrodes to the implanted patient. A first unfit stimulation electrode is fit to the patient by determining a most comfortable loudness (MCL) value. Then an MCL value is determined for each remaining unfit stimulation electrode starting from an initial fitting current based on current spread characteristics of at least one already fit stimulation electrode.

Abstract: An implantable stimulation device is described which includes a flexible carrier member for implantation adjacent to target neural tissue. Carrier wires are embedded within the carrier member for conducting electrical signals. At least one active interface device also is within the carrier member and includes a hermetically sealed device housing without penetration by any electrical conductor, an active interface element within the device housing, an inductive link arrangement providing an electrical connection between the active interface element and a terminal end of one of the carrier wires, and an outer interface surface adjacent to the target neural tissue that provides a communication link between the adjacent target neural tissue and the active interface element.

Abstract: An exemplary electro-acoustic stimulation (EAS) device includes 1) a detection facility configured to detect audio content presented to a patient and included in an acoustic stimulation frequency range, 2) an acoustic stimulation management facility configured to direct a loud-speaker to apply acoustic stimulation representative of the audio content included in the acoustic stimulation frequency range to the patient, and 3) an electrical stimulation management facility configured to direct a cochlear implant implanted within the patient to apply sub-threshold electrical stimulation to the patient by way of one or more electrodes disposed within an apical region of a cochlea of the patient together with the application of the acoustic stimulation. Corresponding systems and methods are also disclosed.

Abstract: An implantable stimulation device that includes output current sources and/or sinks configured to provide an output current for a load (i.e., tissue). The output path of the output current source or sink comprises a transistor which operates in a linear mode instead of a saturation mode. Because operation in a linear mode results in smaller drain-to-source voltage drops, power consumption in the output current source or sink (and hence in the implantable stimulator) is reduced, reducing battery or other power source requirements. Operation in the linear mode is facilitated by a load in an input path and a load in the output path (which bears the output current). The loads can be active transistors or passive resistors. A feedback circuit (e.g., an operational amplifier) receives voltages that build up across these loads, and sends a control signal to the gate of the transistor to ensure its linear operation.

Abstract: A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators to control neurological state and prevent neurological signs and symptoms. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

Abstract: This disclosure describes techniques that support delivering electrical stimulation current via at least two user-selected electrodes of an implantable medical device (IMD) and automatically delivering balancing current below via at least one non-selected electrode. Balancing currents delivered via the at least one non-selected electrode may be configured with an amplitude below a perception threshold of a patient. Delivery of balancing current via the at least one third electrode may allow an implantable medical device to automatically balance the total current delivered to a patient.

Abstract: A stimulator and a method for the treatment of intractable pain syndromes by electrical stimulation of the spinal cord is disclosed in which implantable electrodes positioned around a targeted area of the spinal cord transmit an interferential current that has a base medium frequency alternating current between 500 Hz-20 KHz. A digital signal processor generates a sine-wave-like waveform from a pulse generator which after further processing is used to generate at least two circuits for use in producing the beat frequency signal. An effective area of stimulation is controlled by the quantity of electrodes, positioning of the electrodes and electrode cross pattern orientation. Amplitude modulation of electrical circuits created at the electrode placements also augments the effective area of stimulation. The stimulator and method reduce accommodation of the body to the electrical stimulation and provide deeper penetration of the resultant signal.

Abstract: A method that electrically stimulates a heart muscle to alter the ejection profile of the heart, to control the mechanical function of the heart and reduce the observed blood pressure of the patient. The therapy may be invoked by an implantable blood pressure sensor associated with a pacemaker like device. In some cases, where a measured pretreatment blood pressure exceeds a treatment threshold, a patient's heart may be stimulated with an electrical stimulus timed relative to the patient's cardiac ejection cycle. This is done to cause dyssynchrony between at least two cardiac chambers or within a cardiac chamber, which alters the patient's cardiac ejection profile from a pretreatment cardiac ejection profile. This has the effect of reducing the patient's blood pressure from the measured pretreatment blood pressure.

Abstract: A non-invasive bodily-attached ambulatory medical monitoring and treatment device with pacing is provided. The noninvasive ambulatory pacing device includes a battery, at least one therapy electrode coupled to the battery, a memory storing information indicative of a patient's cardiac activity, and at least one processor coupled to the memory and the at least one therapy electrode. The at least one processor is configured to identify a cardiac arrhythmia within the information and execute at least one pacing routine to treat the identified cardiac arrhythmia.

Abstract: The present disclosure pertains to cardiac pacing methods and systems, and, more particularly, to cardiac resynchronization therapy (CRT). In particular, the present disclosure pertains to determining the efficacy of CRT through use of an effective capture test (ECT). One or more embodiments comprises sensing a signal in response to a ventricular pacing stimulus. Through signal processing, a number of features are parsed from the signal. Exemplary features parsed from the signal include a maximum amplitude, a maximum time associated with the maximum amplitude, a minimum amplitude, and a minimum time associated with the minimum amplitude. The data is evaluated through use of the ECT. By employing the ECT, efficacy of CRT is easily and automatically evaluated.

Abstract: An apparatus may include an implantable therapy circuit that provides bi-ventricular pacing to a subject, a heart sound signal sensing circuit that produces a sensed heart sound signal that is representative of at least one heart sound associated with mechanical cardiac activity, a memory circuit to store one or more heart sound templates of cardiac capture, and a comparison circuit that compares a segment of the sensed heart sound signal to the one or more heart sound templates of cardiac capture to identify ventricles in which cardiac capture was induced by the bi-ventricular pacing. In some situations, an indication of the ventricles in which cardiac capture was induced may be generated according to the comparison.

Abstract: The present invention provides a thin and flexible device and method of use thereof for pain and wound treatment of a subject. The integrated surface stimulation device may comprise a complete wireless stimulation system in a disposable and/or reusable flexible device for widespread use in multiple therapeutic applications. The invention would be situated on the skin surface of a patient and would be activated so as to reduce the overall occurrence of pain and/or increase wound healing rates. As provided, the device will comprise an integrated power supply and pre-programmable stimulator/control system mounted on the upper face of a flexible polymeric substrate layer. The lower face of the substrate layer will comprise areas of stimulating electrodes, applied using thin film coating techniques. The device can then be applied to the user with a medical grade pressure sensitive adhesive coating provided on the lower face of the substrate layer.

Abstract: Methods and apparatus for delivering therapy from an implanted neurostimulator to a patient are provided. One feature is an external controller that acts as a gateway for therapy. The external controller can be a handheld controller that communicates wirelessly with the implanted neurostimulator. In some embodiments, the controller communicates with a database to determine a therapy approval status of the neurostimulator. Therapy can be approved by a physician prescription, or by prepayment, for example. In some embodiments, the neurostimulator is deactivated when no approved therapies remain.

Abstract: An accessory (11) for use with an implanted medical device (100, 102) in a mammal body is intended for use externally to said mammal body and is arranged to wirelessly transmit signals to said implanted medical device (100,102). Said signals are sent in order to initiate a backup function or a backup system in said implanted medical device. The signals can be sent to initiate said backup function or backup system to override a built in control and/or powering system of the implanted device (100, 102). Also, the accessory can send said signals as wireless power signals to a receiver (102) for wirelessly receiving power in said implanted medical device, the signal information regarding the backup function being coded into said power signals.

Abstract: An implantable pulse generator (IPG) is fabricated by utilizing a lead body with a plurality of conductors enclosed in insulative material along a first length of the conductors, and a second length of the conductors being exposed. A tubular structure is placed over the lead body with the plurality of conductors extending through it. A feedthrough assembly includes a plurality of feedthrough pins surrounded by insular material with a ferrule extending about an outer surface of the feedthrough assembly. The plurality of conductors are attached to the plurality of feedthrough pins and the ferrule of the feedthrough assembly is welded to the tubular structure to form an intermediate assembly. The intermediate assembly is then welded to one or more housing components of the IPG providing a hermetically seal. A connector portion on a distal end of the lead body is provided to electrically connect to terminals of a stimulation lead.

Abstract: The present invention relates to a radiofrequency (RF) hyperthermia device for capacitive coupling comprising a radiofrequency source, an amplifier, a sensor, a feedback amplifier and a modulation signal generator, wherein the radiofrequency source produces a source signal which is modulated by the modulation signal generator, amplified by the amplifier and directed to a target, the sensor receives a feed back signal from the target that is directed to the feed back amplifier, wherein the feedback signal is amplified by the feedback amplifier and modulates the source signal to generate a target modified signal. This radiofrequency (RF) hyperthermia device is designed for increasing the selectivity of the hyperthermia treatment.

Abstract: A deep magnetic field generating apparatus includes a first coil unit and a second coil unit. The second coil unit is connected with the first coil unit, and disposed around the first coil unit horizontally. Accordingly, the deep magnetic field generating apparatus can generate a desired deep magnetic field.

Abstract: Pulsed electromagnetic field (PEMF) apparatuses and methods of making and using them. In particular, described herein are two-part PEMF apparatuses that include a self-contained, lightweight, small, compact (e.g., in some variations, wearable) generator unit that is adapted to releasably and replaceably mate with an applicator unit. The generator unit typically includes a power source and a controller that generated PEMF waveforms to be applied, including the shape and timing of the PEMF waveforms. The applicator unit typically includes a radio frequency (RF) power amplifier, a loop antenna, and impedance matching circuitry for matching the impedances for the connection between the antenna loop and the RF power amplifier. Thus, the generator module may control the application of PEMF signals without requiring impedance matching between the separable generator unit and the applicator unit. The applicator unit can include a plurality of variable capacitors that can be used to tune the PEMF signals.

Abstract: Endoscopic delivery of Red/NIR light to the Substantia Nigra to treat Parkinson's Disease in order to raise the energy levels in the substantia nigra.

Abstract: Intracavitary brachytherapy tandem and ovoid oncology treatment systems and methods are provided. One such system and method employs a multi-part tandem having a detachable distal section suitable for retaining within a body cavity such as the uterus, both during radiation treatment and during recovery time between radiation treatments. This distal portion can be intended for single-patient use and be disposed of after completion of a radiation treatment session having multiple radiation dose treatment times. One or both of real time in vivo detection and monitoring and hypertherapy features can be included. One or more of the system tandem or ovoid colpostats feature bendability to tailor the system to the specific body and patient being treated. The method includes having a tandem distal section inserted into a body cavity such as a uterus and remaining within the body cavity in between treatment times.

Abstract: Radiosurgical treatments of tissues of the heart mitigate arrhythmias and treat other tumerous and non-tumerous disease using an implanted fiducial positioned in or near the heart using cardiac catheterization techniques. The fiducials may be implanted after diagnostic and planning images of the target tissues have been acquired. Fiducial implantation may take place the day of a scheduled radiosurgical treatment. Techniques to accommodate post-planning fiducial implantation may include registration of the implanted fiducial location with the treatment plan, and active fiducials may limit collateral imaging radiation exposure while enhancing tracking accuracy.

Abstract: A system for radiotherapy includes a couch having a top lateral surface upon which a patient being treated by the system is positioned. The couch has continuous arc rotation for delivery of accelerated irradiation to the patient. The couch is movable rotationally and translationally. Delivery of the accelerated irradiation is performed during at least a portion of the movement.

Abstract: The invention provides for medical instrument (800, 1000) comprising a magnetic resonance imaging system. Execution of the instruction cause a processor controlling the instrument to: execute (900) a magnetic resonance data processing application (42, 852) thereby providing a plug-in framework, execute (902) a protocol definition interface to load a first selection (858) of the plug-ins into the plug-in framework, acquire (904) the magnetic resonance data by using the pulse sequence data to control the magnetic resonance imaging system; and reconstruct (906) a magnetic resonance image from the magnetic resonance data using the first selection of the plug-ins.

Abstract: A method of treating a condition associate with accumulation of an agent in cells in a patient includes exposing the cells to ultrasound, to selectively kill or induce apoptosis in the cells. The cells include the accumulated agent.

Abstract: The present invention relates to a composition for coating keratin fibers, more particularly the eyelashes, characterized in that it is present in the form of a wax-in-water emulsion comprising a combination of at least one glutamic acid derivative and/or salt thereof and at least one alkylpolyglycoside.

Abstract: Compositions and methods for treating or preventing fungal infections of the nail are provided. The topical composition includes the use of chlorine dioxide, chlorite salts, benzoyl peroxide, an alpha hydroxy acid, antifungal and antibiotic agents. Also provided is a heat-generating device for use in treating at least one nail infected with fungus and a toe sock device.

Abstract: Transparent antiperspirant compositions in the form of a water-in-oil emulsion containing a balanced mixture of selected oil components and emulsifiers, thereby improving the antiperspirant effect of the compositions.

Abstract: Face masks that can be used, for example, in medical and surgical procedures, including both completely or partially disposable and reusable masks, that can be custom fitted to the wearer, and which can include one or more filtering inhalation and exhalation valves and/or compartments allowing for separated filtering of inhalation and exhalation gases. Some embodiments include systems, methods and kits for reducing contaminants in an inhalation and exhalation flow stream.

Abstract: Apparatus and associated methods relate to a safety interface device that securely attaches to a length of webbing, while simultaneously providing a plurality of non-intersecting apertures to couple to a corresponding plurality of safety devices. In some embodiments, the safety interface device may be retrofitted to a closed webbing on a pre-fabricated safety harness. In some exemplary embodiments, the element may be opened and closed by providing two pivotably coupled plates, permitting the webbing to be installed when the plates are opened, and secured when the plates are closed. Various embodiments, for example, provide a securing pin which automatically locks the device to the webbing when the device is closed around the webbing. In some embodiments, the device will be again locked in a secondary fashion whenever a safety device is attached to the interface plate. Thus, at least two distinct actions may be required to open the device.

Abstract: An improved fall arrest lanyard apparatus and method for decelerating and arresting a user from impacting the ground after a fall, along with an integrated, deployable etrier. After the fall sequence has ended, the user may use the etrier to relieve tension in an upper portion of the lanyard and thereby disconnect the lanyard from the user while suspended.

Abstract: Embodiments of the present invention are directed towards fire blocking apparatuses that include fire skirts that extend off edges of solar panels installed on roofs. The fire skirts are configured to block the gap between a solar panel and the roof surface on which it is installed to prevent or suppress the ignition for spreading of fire underneath the solar panel. Some of the fire skirts are heat or fire sensitive and are configured to the melt, deform, or otherwise be altered upon the application of a threshold temperature such that the fire skirts block the gap between the solar panel and the roof surface. Other embodiments are directed towards fire skirts that include a solar panel mounting surface and a shelf surface configured to accommodate ballast or fasteners to affix the solar panel to the roof surface. Such embodiments can be formed from pre-scored or pre-folded sheet materials.

Abstract: A sprinkler protection system for protecting an existing sprinkler installation includes housing sections that cooperate to cover a majority of a sprinkler unit, such as a ceiling-mounted sprinkler unit. The housing sections can include one or more apertures aligned with a deflector of the sprinkler to permit the deflector to direct water through the aperture and out of the housing without significantly impeding the water output of the sprinkler and offer greater protection to the sprinkler unit.